Overexpression of miR-141 promotes proliferation of NSCLC cells in vitro and cancer growth in vivo through downregulation of PI3K/AKT signaling antagonists, protein phosphatases PHLPP1 and PHLPP2. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.